Last updated: 11/16/2021 05:40:04
GSK study ID
102230
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title:
Trial description:
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
2005-20-05
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Jiří Beran, Ana Ramirez Villaescusa, Raghavendra Devadiga, Thi Lien-Anh Nguyen, Olivier Gruselle, Jean-Yves Pirçon, Frank Struyf, Jeanne-Marie Devaster. Respiratory syncytial virus acute respiratory infections in ≥ 65-year-old adults in long-term care facilities in the Czech Republic. Cent Eur J Public Health. 2021;29(3):167-176.
DOI: http://dx.doi.org/ 10.21101/cejph.a6861
Medical condition
Respiratory Syncyctial Virus Vaccines, Hypoglycemia
Product
GSK2647160A
Collaborators
Not applicable
Study date(s)
August 2004 to May 2005
Type
Interventional
Phase
Not applicable
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
Location
GSK Investigational Site
Hradec Kralove, Czech Republic, 500 03
Status
Study Complete
Study documents
No study documents available.
Results overview
Study Results yet to be posted
Recruitment status
Study complete
Actual primary completion date
2005-20-05
Actual study completion date
2005-20-05
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Additional information
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website